Mayne Pharma
Eva Zalanyi has extensive experience in analytical development, currently serving as the Analytical Development Team Leader at Mayne Pharma since May 2007, after holding the position of Senior Development Chemist. Prior to this role, Eva worked at Alpharma from April 2002 to May 2007, where responsibilities included Analytical Development Manager, Analytical Development Group Leader, and Senior Research Scientist. Eva Zalanyi holds a Master's degree in Chemical Engineering and Organic Chemistry from Universitatea „Politehnica” din Timișoara, obtained between 1972 and 1977.
Mayne Pharma
1 followers
Mayne Pharma Group Ltd is an Australia-based specialty pharmaceutical company. The Company is focused on commercializing branded and generic pharmaceuticals. It operates through four segments: Generic Products (GPD), Specialty Brands (SBD), Metrics Contract Services (MCS) and Mayne Pharma International (MPI). The GPD segment is engaged in the manufacture and distribution of generic pharmaceutical products in the United States. The SBD segment markets and distributes specialty branded pharmaceutical products in the United States. The MCS segment is engaged in the provision of contract analytical and pharmaceutical development services to third-party customers in the United States. The MPI segment is engaged in Australian manufacture and sale of branded and generic pharmaceutical product globally and provision of contract manufacturing services to third-party customers within Australia.